ARCHIVES

ODAC Endorses Tamoxifen Trial, With Modification to Ensure Enrollment of Women At Higher Risk

This article is from The Cancer Letter archive.

Vol. 17 No. 31 | August 2, 1991

Download PDF Visit The Full Archive

Related Articles

In Myriad Case, the Supreme Court Hears About Tree Leaves, Baseball and Cookies

April 19, 2013

Statement Defining Cancer Control Goals, Approaches Okayed By Board

February 6, 1981

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982

Guest Editorial “Gizmo Idolatry” and Marketing Da Vinci’s Radical Robot

September 26, 2014

Elderly Men Say Physicians Are Recommending PSA Tests

December 26, 2003

Panel To Take Up Issues In Grant/Peer Review System, Consider NCAB Membership Requirements

December 11, 1981